Author Correction: Intrathecal onasemnogene abeparvovec for treatment-experienced patients with spinal muscular atrophy: a phase 3b, open-label trial. - Kwon JM; Munell F; Le Goff L; Yuge K; Kato T; Cances C; De Waele L; Woodcock IR; Mercuri EM; Proud CM; Darras BT; Hayes LH; et al. (Nature medicine, 2026)